Penile cancer is rare but treatable, with squamous cell carcinoma being the most common type. Key risk factors include HPV, phimosis, smoking, and age. Diagnosis involves physical exams, biopsies, and ...

EPIC-A: Phase II trial of cemiplimab plus standard of care chemotherapy followed by maintenance cemiplimab in locally advanced or metastatic penile carcinoma.

Penile squamous cell carcinoma (PSCC) is a rare but aggressive malignancy that severely affects men’s health worldwide. Half of all PSCC cases are linked to human papillomavirus (HPV) infection, yet ...

Yet sexual health is frequently sidelined, with men delaying treatment due to embarrassment, uncertainty, or the hope that symptoms will simply resolve on their own. This hesitation can be costly, as ...